Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP

Watchlist Manager
Apollo Hospitals Enterprise Ltd Logo
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
Watchlist
Price: 7 065 INR -0.44%
Market Cap: 1T INR

Apollo Hospitals Enterprise Ltd
Investor Relations

In the bustling corridors of Indian healthcare, Apollo Hospitals Enterprise Ltd. stands as a beacon of innovation and quality healthcare service. Founded in 1983 by Dr. Prathap C. Reddy, Apollo was one of the pioneers in bringing private healthcare to India, setting a new benchmark for service standards in the industry. It positioned itself as a leader by establishing a network of nearly 70 hospitals across the nation, offering a comprehensive range of services from routine and preventive care to complex surgeries and cancer treatments. This extensive network allows Apollo to capitalize on economies of scale, optimize resource allocation, and deliver cost-effective healthcare solutions. Its sophisticated hospitals often boast the latest medical technologies and employ highly trained healthcare professionals, ensuring patients receive top-notch care.

Beyond its core hospital operations, Apollo has diversified its revenue streams through pharmacies, primary care and diagnostic clinics, telemedicine, and healthcare consulting. The pharmacy business, with a massive network of stores, not only serves walk-in customers but also acts as a critical logistical backbone for the hospitals, providing an integrated supply of medicines and healthcare products. This vertical integration ensures availability and enhances the patient experience while contributing significantly to the company’s bottom line. By embracing a digital-first approach, Apollo's telemedicine and health tech investments are bridging gaps in healthcare accessibility, particularly for rural or underserved populations. Altogether, Apollo Hospitals Enterprise Ltd. has created a robust model that not only addresses the healthcare needs of millions but also consistently generates substantial revenue growth.

Show more
Loading
APOLLOHOSP
BSE Sensex 30
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Nov 7, 2025
AI Summary
Q2 2026

Revenue Growth: Apollo Hospitals reported consolidated revenue of INR 6,304 crores for Q2, up 13% year-on-year, with strong performances across all business verticals.

Profitability: Consolidated EBITDA rose 15% YoY to INR 941 crores, and PAT for H1 was INR 910 crores, up 33% YoY.

Healthcare Services: The Healthcare Services division saw 9% revenue growth, robust margins at 24.6%, and improved case mix driving higher revenue per patient.

Digital & Pharmacy: Apollo HealthCo revenues grew 17% YoY; the digital platform Apollo 24/7 added 3 million new users and reduced losses by 30% YoY.

Expansion Plans: Six new hospitals are being commissioned through FY '26–'27, with costs and ramp-up staggered; EBITDA losses from new hospitals expected to be INR 150 crores next year.

Margin Outlook: Management expects stable to improving margins, aided by efficiency programs and cost controls, despite new hospital operating expenses.

Guidance & Outlook: Organic growth in Healthcare Services targeted at 13% annually, with new capacity expected to add an extra 5% over three years. Digital and pharmacy businesses remain on track for breakeven as planned.

Key Financials
Consolidated Revenue
INR 6,304 crores
Consolidated EBITDA
INR 941 crores
Healthcare Services Revenue
INR 3,169 crores
Healthcare Services EBITDA
INR 781 crores
Healthcare Services Margin
24.6%
Apollo HealthCo Revenue
INR 2,661 crores
Apollo Health & Lifestyle Revenue
INR 474 crores
Apollo HealthCo EBITDA
INR 110 crores
AHLL EBITDA
INR 50 crores
Group-wide Occupancy
69%
Average Revenue per Patient (ARPC)
INR 173,318
Return on Capital Employed (ROCE)
30.3%
Apollo 24/7 Users
44 million users
Platform GMV (Apollo 24/7)
INR 723 crores
Pharmacy Distribution EBITDA
INR 181 crores
Digital Vertical Loss
INR 71 crores
PAT (H1)
INR 910 crores
Consolidated Revenue (H1)
INR 12,146 crores
Consolidated EBITDA (H1)
INR 1,793 crores
Earnings Call Recording
Other Earnings Calls

Management

Dr. Prathap Chandra Reddy FCCP, FICA, FRCS, M.D., MBBS
Founder & Executive Chairman
No Bio Available
Ms. Suneeta Reddy
MD & Executive Director
No Bio Available
Dr. Sangita Reddy M.D.
Joint MD & Executive Director
No Bio Available
Dr. P. Preetha Reddy B.Sc., M.D.
Executive Vice-Chairperson
No Bio Available
Mr. Krishnan Akhileswaran
Chief Financial Officer
No Bio Available
Mr. S. M. Krishnan
Senior VP of Finance, Compliance Officer & Company Secretary
No Bio Available
Mr. Krishnaswami Padmanabhan
Group President
No Bio Available
Ms. Sindoori Reddy
Vice President of Operations
No Bio Available
Mr. G. Dasaratha Rama Reddy
Senior General Manager of Finance & Accounts
No Bio Available
Mr. Binod Madhab Samal
Chief Technology Officer
No Bio Available

Contacts

Address
TAMIL NADU
Chennai
Ali Towers, III Floor,, No.55, Greams Road,
Contacts